Clinical Trial Update: Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial comparing dabigatran etexilate to standard of care in paediatric venous thromboembolism completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2020-07-07